Search for: "Anda Pharmaceuticals, Inc"
Results 461 - 480
of 607
Sorted by Relevance
|
Sort by Date
8 Jan 2020, 11:16 am
” Intervet Inc. v. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva,… [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
20 Mar 2017, 9:05 am
Inc., S. [read post]
21 Jul 2010, 1:05 am
Biogaran and Laboratoires Medidom (EPLAW) Fortical (Calcitonin) – US: Unigene secures ruling of infringement against Apotex in Fortical patent suit (Patent Docs) Levaquin (Levofloxacin) – US: Federal Circuit denies rehearing petition in Levaquin Patent Term Extension case: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
8 May 2012, 5:59 pm
Plaintiffs sued several generic drug manufacturers, including Morton Grove Pharmaceuticals, Inc. [read post]
11 May 2011, 4:54 am
Allergan, Inc. [read post]
15 Jun 2008, 4:13 pm
National Resources Defense Council, Inc., 467 U.S. 837 (1984).The FDA had reviewed Perrigo's ANDA in 1987 and had again reviewed the liver toxicity issue in 2002. [read post]
13 Jul 2016, 4:21 pm
Hospira Inc., Case No. 14-1469 (Fed. [read post]
13 Jul 2010, 12:02 pm
Just a few weeks later – on February 25, 2010 – FDA approved Nycomed US Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US: OGD’s… [read post]
3 Mar 2010, 5:05 am
(Patent Docs) US: Court report – Numerous false marking suits filed by Simonian against various respondents concerning products including: Claritin-D, Hypo Tears, Interceptor, Prevacid, Advil, Heartguard Heartworm Canine Medication (Patent Docs) US: False marking suit brought over marking of Accu-Chek products: O’Neill v Roche Diagnostics Corp (Patent Docs) US: President’s health care plan includes pay-for-delay ban and biosimilar regulatory pathway (Patent Docs) US: OGD’s… [read post]
21 Jun 2012, 6:52 pm
That’s what happened when we saw the June 23, 2011 approval letter for Lannett Holdings, Inc. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb) General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
24 Nov 2010, 12:37 am
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
15 May 2011, 2:54 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
23 Sep 2010, 12:39 pm
District Court for the District of Columbia challenging FDA’s September 14th approval of Watson Laboratories, Inc. [read post]
